AKASA is a healthcare technology company founded in 2018, headquartered in South San Francisco, California. The company has built its business around generative AI and large language models, applying these technologies specifically to the complex financial operations of hospitals and outpatient facilities.
The firm's core offering is a generative AI platform designed for the healthcare revenue cycle. This system integrates proprietary AI with revenue cycle expertise to automate workflows including prior authorization, clinical documentation improvement, medical coding, and claims management. It is currently deployed across more than 650 hospitals and 6,500 outpatient facilities in all 50 US states.
AKASA has secured over $205 million in funding to support its growth in the healthcare administration vertical. Its operations span the entire country, though its corporate base remains in California's Bay Area biotech corridor.
